Global Dexlansoprazole Sustained Release Capsule Supply, Demand and Key Producers, 2023-2029
The global Dexlansoprazole Sustained Release Capsule market size is expected to reach $ 433.5 million by 2029, rising at a market growth of 5.1% CAGR during the forecast period (2023-2029).
Dexlansoprazole sustained-release capsules were approved by the U.S. FDA in January 2009, under the trade name DEXILANT. For the treatment of heartburn caused by non-erosive gastroesophageal reflux disease (GERD), erosive esophagitis (EE) and maintenance treatment after healing of erosive esophagitis, all of which are administered once a day.
This report studies the global Dexlansoprazole Sustained Release Capsule production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Dexlansoprazole Sustained Release Capsule, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Dexlansoprazole Sustained Release Capsule that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Dexlansoprazole Sustained Release Capsule total production and demand, 2018-2029, (K Units)
Global Dexlansoprazole Sustained Release Capsule total production value, 2018-2029, (USD Million)
Global Dexlansoprazole Sustained Release Capsule production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Dexlansoprazole Sustained Release Capsule consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Dexlansoprazole Sustained Release Capsule domestic production, consumption, key domestic manufacturers and share
Global Dexlansoprazole Sustained Release Capsule production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Dexlansoprazole Sustained Release Capsule production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Dexlansoprazole Sustained Release Capsule production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Dexlansoprazole Sustained Release Capsule market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include TAKEDA PHARM, PAR PHARM and TWI PHARM, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Dexlansoprazole Sustained Release Capsule market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Dexlansoprazole Sustained Release Capsule Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Dexlansoprazole Sustained Release Capsule Market, Segmentation by Type
30MG
60MG
Global Dexlansoprazole Sustained Release Capsule Market, Segmentation by Application
Hospital
Clinic
Companies Profiled:
TAKEDA PHARM
PAR PHARM
TWI PHARM
Key Questions Answered
1. How big is the global Dexlansoprazole Sustained Release Capsule market?
2. What is the demand of the global Dexlansoprazole Sustained Release Capsule market?
3. What is the year over year growth of the global Dexlansoprazole Sustained Release Capsule market?
4. What is the production and production value of the global Dexlansoprazole Sustained Release Capsule market?
5. Who are the key producers in the global Dexlansoprazole Sustained Release Capsule market?
6. What are the growth factors driving the market demand?